Why is Salesforce restarting Informatica acquisition talks?
How did Musk's X outage impact his companies?
What caused SpaceX Starship Flight 8 explosion?
Why is Trump threatening tariffs on Apple iPhones?
How will US Steel-Nippon Steel partnership affect steel market?
What risks arise from Trump's new EU tariff threats?
Why is McDonald’s closing its CosMc’s spin-off?
How is AI reshaping JPMorgan’s investment strategy?
What explains recent sell-off in Apple stock?
Delivers Oncology Milestones with MesoC2 Debut and XTANDI Survival Boost
finance.yahoo.com/news/pfizer-inc-pfe-delivers-oncology-145939821.html
In This Article:
Pfizer Inc. (NYSE:PFE) has unveiled major advances in cancer research at the 2025 ASCO Annual Meeting, spotlighting robust five-year survival results for XTANDI (enzalutamide) combined with androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate…
This story appeared on finance.yahoo.com, 2025-05-24 14:59:39.